Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A. is a biotechnology company focused on the research, development, and marketing of therapies aimed primarily at neurological and psychiatric disorders. Leveraging cutting-edge science, Newron Pharmaceuticals is dedicated to addressing unmet medical needs by creating innovative drugs that could potentially transform the treatment landscape for diseases such as Parkinson’s and schizophrenia. The company is renowned for its robust pipeline of clinical-stage neuroscience compounds, with several candidates undergoing advanced clinical trials. Its strategic collaborations with pharmaceutical giants enhance its research capabilities and global market reach. Newron Pharmaceuticals plays a crucial role in the biopharmaceutical industry, contributing significantly to the advancements in neuropsychiatric study and care. Based in Bresso, Italy, the company continuously endeavors to improve patients' quality of life through science-driven, patient-centric approaches.